These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 30962036)

  • 1. Hepatitis C treatment outcomes among homeless-experienced individuals at a community health centre in Boston.
    Beiser ME; Smith K; Ingemi M; Mulligan E; Baggett TP
    Int J Drug Policy; 2019 Oct; 72():129-137. PubMed ID: 30962036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors Associated with Sustained Virologic Response to Hepatitis C Treatment in a Homeless-Experienced Cohort in Boston, 2014-2020.
    Beiser ME; Shaw LC; Wilson GA; Muse KO; Shores SK; Baggett TP
    J Gen Intern Med; 2023 Mar; 38(4):865-872. PubMed ID: 36127534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis C Virus Reinfection in a Real-World Cohort of Homeless-Experienced Individuals in Boston.
    Beiser ME; Shaw LC; Shores SK; Carson JM; Hajarizadeh B
    Clin Infect Dis; 2023 Jul; 77(1):46-55. PubMed ID: 36869823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reinfection following successful direct-acting antiviral therapy for HCV infection among people attending an inner-city community health centre in Victoria, Canada.
    Selfridge M; Cunningham EB; Barnett T; Drost A; Gray-Schleihauf C; Guarasci K; Lundgren K; Milne R; Grebely J; Fraser C
    Int J Drug Policy; 2021 Oct; 96():103418. PubMed ID: 34538704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C Virus Reinfection Among People Who Inject Drugs: Long-Term Follow-Up of the HERO Study.
    Litwin AH; Tsui JI; Heo M; Mehta SH; Taylor LE; Lum PJ; Feinberg J; Kim AY; Norton BL; Pericot-Valverde I; Arnsten J; Meissner P; Karasz A; McKee MD; Ward JW; Johnson N; Agyemang L; Stein ES; Thomas A; Borsuk C; Blalock KL; Wilkinson S; Wagner K; Carty J; Murray-Krezan C; Anderson J; Jacobsohn V; Luetkemeyer AF; Falade-Nwulia O; Groome M; Davies S; Costello K; Page K;
    JAMA Netw Open; 2024 Aug; 7(8):e2430024. PubMed ID: 39186268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct-acting antiviral treatment for hepatitis C, reinfection and mortality among people attending an inner-city community health centre in Victoria, Canada.
    Selfridge M; Cunningham EB; Milne R; Drost A; Barnett T; Lundgren K; Guarasci K; Grebely J; Fraser C
    Int J Drug Policy; 2019 Oct; 72():106-113. PubMed ID: 31178254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Office-Based Addiction Treatment Retention and Mortality Among People Experiencing Homelessness.
    Fine DR; Lewis E; Weinstock K; Wright J; Gaeta JM; Baggett TP
    JAMA Netw Open; 2021 Mar; 4(3):e210477. PubMed ID: 33662132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C virus reinfection after successful treatment with direct-acting antiviral therapy in a large population-based cohort.
    Rossi C; Butt ZA; Wong S; Buxton JA; Islam N; Yu A; Darvishian M; Gilbert M; Wong J; Chapinal N; Binka M; Alvarez M; Tyndall MW; Krajden M; Janjua NZ;
    J Hepatol; 2018 Nov; 69(5):1007-1014. PubMed ID: 30142429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence, risk factors, and prevention of hepatitis C reinfection: a population-based cohort study.
    Islam N; Krajden M; Shoveller J; Gustafson P; Gilbert M; Buxton JA; Wong J; Tyndall MW; Janjua NZ;
    Lancet Gastroenterol Hepatol; 2017 Mar; 2(3):200-210. PubMed ID: 28404135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Results of a Model of Delivering Hepatitis C Care in a Homeless Metropolitan Population in England.
    Guerra-Veloz MF; Han K; Oakes K; Robertson D; Mohamed A; Cannon M; Barnabas A; Shah S; Halford R; Dusheiko G; Agarwal K
    Am J Gastroenterol; 2023 Jun; 118(6):991-1000. PubMed ID: 36191276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reinfection with hepatitis C virus following sustained virological response in injection drug users.
    Grebely J; Knight E; Ngai T; Genoway KA; Raffa JD; Storms M; Gallagher L; Krajden M; Dore GJ; Duncan F; Conway B
    J Gastroenterol Hepatol; 2010 Jul; 25(7):1281-4. PubMed ID: 20594256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A hepatitis C elimination model in healthcare for the homeless organization: A novel reflexive laboratory algorithm and equity assessment.
    Seaman A; King CA; Kaser T; Geduldig A; Ronan W; Cook R; Chan B; Levander XA; Priest KC; Korthuis PT
    Int J Drug Policy; 2021 Oct; 96():103359. PubMed ID: 34325969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug Overdose Mortality Among People Experiencing Homelessness, 2003 to 2018.
    Fine DR; Dickins KA; Adams LD; De Las Nueces D; Weinstock K; Wright J; Gaeta JM; Baggett TP
    JAMA Netw Open; 2022 Jan; 5(1):e2142676. PubMed ID: 34994792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychosocial Factors and the Care Cascade for Hepatitis C Treatment Colocated at a Syringe Service Program.
    Winetsky D; Burack D; Antoniou P; Garcia B; Gordon P; Scherer M
    J Infect Dis; 2020 Sep; 222(Suppl 5):S392-S400. PubMed ID: 32877544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C virus treatment in people who inject drugs (PWID) in Bangladesh.
    Rahman M; Janjua NZ; Shafiq TKI; Chowdhury EI; Sarker MS; Khan SI; Reza M; Faruque MO; Kabir A; Anis AH; Azim T
    Int J Drug Policy; 2019 Dec; 74():69-75. PubMed ID: 31542689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C virus care cascade in persons experiencing homelessness in the United States in the era of direct-acting antiviral agents: A scoping review.
    Del Rosario A; Eldredge JD; Doorley S; Mishra SI; Kesler D; Page K
    J Viral Hepat; 2021 Nov; 28(11):1506-1514. PubMed ID: 34314081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HCV Testing and Treatment in a National Sample of US Federally Qualified Health Centers during the Opioid Epidemic.
    Assoumou SA; Wang J; Nolen S; Eftekhari Yazdi G; Mayer KH; Puro J; Salomon JA; Linas BP
    J Gen Intern Med; 2020 May; 35(5):1477-1483. PubMed ID: 32133577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of hepatitis C treatment outcomes in a harm reduction-focused primary care program in New York City.
    Ziff J; Vu T; Dvir D; Riazi F; Toribio W; Oster S; Sigel K; Weiss J
    Harm Reduct J; 2021 Mar; 18(1):38. PubMed ID: 33789691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low rate of reinfection among a cohort of people who use drugs successfully treated for hepatitis C virus infection in Vancouver, Canada.
    Holeksa J; Magel T; Alimohammadi A; Thiam A; Yung R; Chu L; Truong D; Conway B
    Int J Drug Policy; 2019 Oct; 72():177-180. PubMed ID: 31176594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimating the Prevalence of Advanced Fibrosis in Homeless Adults with Hepatitis C in Boston.
    Beiser ME; Cardoso L; Gaeta JM; Baggett TP
    J Health Care Poor Underserved; 2020; 31(1):128-139. PubMed ID: 32037322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.